BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
PBX1
,
cell-cell adhesion
,
Leukemia
,
Hippocampus
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LILRB4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Myeloid cells of peripheral blood
Monocyte of peripheral blood
Macrophage of peripheral blood
Mononuclear cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bacterial septicemia
Acne
Protozoan infection
Bacterial infection of skin
Septicemia due to Klebsiella
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Chlorprothixene
clemizole
Lithocholic Acid
Ethynodiol Diacetate
fosfosal
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
AATF
IKZF3
RIPK1
PA2G4
FGFR1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
Effect of Mesenchymal Stem Cells on ILT3 Expression in the Splenocytes of Skin Graft Recipient Mice.
Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates wit…
Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibody-producing plasma…
Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiati…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
LILRB4 STAR-T Cell Therapy for Monocytic Leukemia
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors
IO-202 as Monotherapy and IO-202 Plus Azacitidine in Patients in AML and CMML
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ